Biora Therapeutics Profit Margin

Biora Therapeutics (BIORQ) currently reports a profit margin of -1787.93% as of September 2024. That compares with -704155.56% in the prior-year period — up 99.7% year over year. That is below the Healthcare sector average of 10.58%. Use the charts on this page to explore Biora Therapeutics's profit margin history and peer comparisons.

Biora Therapeutics's profit margin increased from -704155.56% to -1787.93% — a 99.7% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biora Therapeutics's profit margin of -1787.93% is lower than the Healthcare sector average of 10.58%. That is roughly 16998.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Biora Therapeutics's current -1787.93% should be judged against Healthcare norms (sector average: 10.58%) and against BIORQ's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1787.93%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for Biora Therapeutics, and consider following BIORQ for alerts when major investors trade the stock.